Business Segments · Goodwill (Note 11)

Europe — Goodwill (Note 11)

Edwards Lifesciences Europe — Goodwill (Note 11) increased by 12.7% to $62.20M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 12.7%, from $55.20M to $62.20M.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2013
Last reportedQ4 2025
Rolls up toGoodwill

How to read this metric

An increase typically reflects recent acquisitions in the region, while a decrease may indicate impairment charges or divestitures.

Detailed definition

This metric represents the total carrying value of goodwill allocated to the European business segment. It reflects the...

Peer comparison

Peers in the medical device industry report similar goodwill balances based on their regional M&A activity and historical purchase price allocations.

Metric ID: ew_segment_europe_goodwill_note_11

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$63.00M$59.40M$61.40M$55.20M$62.20M
QoQ Change-5.7%+3.4%-10.1%+12.7%
YoY Change-5.7%+3.4%-10.1%+12.7%
Range$55.20M$63.00M
CAGR-1.3%
Avg YoY Growth+0.1%
Median YoY Growth-1.2%

Frequently Asked Questions

What is Edwards Lifesciences's europe — goodwill (note 11)?
Edwards Lifesciences (EW) reported europe — goodwill (note 11) of $62.20M in Q4 2025.
How has Edwards Lifesciences's europe — goodwill (note 11) changed year-over-year?
Edwards Lifesciences's europe — goodwill (note 11) increased by 12.7% year-over-year, from $55.20M to $62.20M.
What does europe — goodwill (note 11) mean?
The total value of goodwill recorded specifically for the company's European business operations.